Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1990 Apr 28;300(6732):1131–1132. doi: 10.1136/bmj.300.6732.1131

Are drugs targeted at Alzheimer's disease useful? 1. Useful for what?

R Levy 1
PMCID: PMC1662820  PMID: 2344540

Full text

PDF
1131

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartus R. T., Dean R. L., 3rd, Beer B., Lippa A. S. The cholinergic hypothesis of geriatric memory dysfunction. Science. 1982 Jul 30;217(4558):408–414. doi: 10.1126/science.7046051. [DOI] [PubMed] [Google Scholar]
  2. Bowen D. M., Smith C. B., White P., Davison A. N. Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain. 1976 Sep;99(3):459–496. doi: 10.1093/brain/99.3.459. [DOI] [PubMed] [Google Scholar]
  3. Davies P., Maloney A. J. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet. 1976 Dec 25;2(8000):1403–1403. doi: 10.1016/s0140-6736(76)91936-x. [DOI] [PubMed] [Google Scholar]
  4. Davis K. L., Mohs R. C. Cholinergic drugs in Alzheimer's disease. N Engl J Med. 1986 Nov 13;315(20):1286–1287. doi: 10.1056/NEJM198611133152008. [DOI] [PubMed] [Google Scholar]
  5. Drukarch B., Kits K. S., Van der Meer E. G., Lodder J. C., Stoof J. C. 9-Amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K+ current. Eur J Pharmacol. 1987 Sep 2;141(1):153–157. doi: 10.1016/0014-2999(87)90424-9. [DOI] [PubMed] [Google Scholar]
  6. KAUL P. N. Enzyme inhibiting action of tetrahydroaminoacridine and its structural fragments. J Pharm Pharmacol. 1962 Apr;14:243–248. doi: 10.1111/j.2042-7158.1962.tb11086.x. [DOI] [PubMed] [Google Scholar]
  7. Little A., Levy R., Chuaqui-Kidd P., Hand D. A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1985 Aug;48(8):736–742. doi: 10.1136/jnnp.48.8.736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Perry E. K., Gibson P. H., Blessed G., Perry R. H., Tomlinson B. E. Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. J Neurol Sci. 1977 Nov;34(2):247–265. doi: 10.1016/0022-510x(77)90073-9. [DOI] [PubMed] [Google Scholar]
  9. Perry E. K. The cholinergic hypothesis--ten years on. Br Med Bull. 1986 Jan;42(1):63–69. doi: 10.1093/oxfordjournals.bmb.a072100. [DOI] [PubMed] [Google Scholar]
  10. Perry E. K., Tomlinson B. E., Blessed G., Bergmann K., Gibson P. H., Perry R. H. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J. 1978 Nov 25;2(6150):1457–1459. doi: 10.1136/bmj.2.6150.1457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Summers W. K., Majovski L. V., Marsh G. M., Tachiki K., Kling A. Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. N Engl J Med. 1986 Nov 13;315(20):1241–1245. doi: 10.1056/NEJM198611133152001. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES